Recent Advances in Oncology Imaging: 2nd Edition
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Methods and Technologies Development".
Deadline for manuscript submissions: 28 February 2025 | Viewed by 1244
Special Issue Editors
Interests: preclinical cellular and molecular multimodality imaging, with a particular focus on applications in small animal models of breast, kidney, lung, prostate and bladder cancers
Special Issues, Collections and Topics in MDPI journals
Interests: imaging-navigated translational theragnostic research
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Medical imaging is playing an ever-increasing role in clinical, experimental, and translational oncology for population surveillance, patient screening, diagnosis assurance, cancer staging, therapeutic evaluation, prognosis assessment, and development of novel anticancer approaches.
Recent advances in oncologic imaging include the following: (1) multimodality (US, CT, MRI, PET, SPECT, optical imaging) and multiparametric (morphological, functional, metabolic) applications; (2) precision medicine driven by molecular imaging and nano-technologies; (3) theragnostics that utilize molecular imaging to identify cancer patient-specific biomarkers to guide individualized treatment decisions; and (4) radiomics assisted by artificial intelligence, big data analytics, and deep learning for multi-feature characterization. This Special Issue will update and highlight the state of the art with respect to cancer imaging.
Dr. Li Liu
Prof. Dr. Yicheng Ni
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- medical imaging
- cancer
- oncology
- molecular imaging
- theragnostics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
